Epidemiology of anaphylaxis

Chemical Immunology and Allergy

Volumn 95, Issue , 2010, Pages 12-21

  Worm, Margitta ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEPHALOSPORIN; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOOD ALLERGEN; INSECT VENOM; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G;

AGE DISTRIBUTION; ALLERGY; ANAPHYLAXIS; ATOPY; COMORBIDITY; DRUG FATALITY; FOOD ALLERGY; GEOGRAPHY; GROUPS BY AGE; HUMAN; INCIDENCE; INSECT ALLERGY; MAST CELL; PEANUT ALLERGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; SOCIAL STATUS;

ANAPHYLAXIS; CARDIOVASCULAR DISEASES; COMORBIDITY; DRUG HYPERSENSITIVITY; FOOD HYPERSENSITIVITY; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS;

EID: 77954845879     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000315935     Document Type: Review

References (49)

1. Lieberman P: Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol 2008;8:316-320.
2. Anthony F, Brown T, McKinnon D, Chu K: Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001;108:861-866.
3. Kane KE, Cone DC: Anaphylaxis in the prehospital setting. J Emerg Med 2004;27:371-377.
4. Smit DV, Cameron PA, Rainer TH: Anaphylaxis presentation in a emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med 2005;28:381-388.
5. Kiratiseavee S, Ranesg S: Evaluation of pediatric patients admitted with adverse food reactions to an inner-city pediatric ED. J Allergy Clin Immunol 2007;119:S114.
6. Mulla ZD, Simon MR: Hospitalizations for anaphylaxis in Florida: epidemiologic analysis of a population-based dataset. J Allergy Clin Immunol 2007; 119:S32.
7. Poulos LM, Waters AM, Correl PK, et al: Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol 2007;120:878-884.
8. Webb LM, Lieberman P: Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 2006;97: 39-43.
9. Furlong T, Stivers T, Munoz-Furlong A, Sicherer SH: A registry of self-reported seafood allergy: demographic and allergic characteristic of the first 1,000 registrants. J Allergy Clin Immunol 2005;115: S62.
10. Bohlke K, Davis RL, DeStefano F, et al: Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 2004;113:536-542.
11. Camargo CA, Clark S, Kaplan MS, et al: Regional differences in EpiPen prescriptions in the United States. J Allergy Clin Immunol 2007;120:131-136.
12. Clark S, Camargo CA Jr: Epidemiology of anaphylaxis. Immunol Allergy Clin North Am 2007;27:145-163.
13. Hompes S, Kirschbaum J, Scherer K, Treudler R, Przybilla B, Henzgen M, Worm M: Erste Daten der Pilotphase des Anaphylaxie-Registers im deutschsprachigen Raum. Allergo J 2008;7:550-555.
14. Worm M, Hompes S, Vogel N, Kirschbaum J, Zuberbier T: Care of anaphylaxis among practising doctors. Allergy 2008;63:1562-1563.
15. ZuberbierT, Edenharter G, Worm M, Ehlers I, Reimann S, Hantke T, Roehr CC, Bergmann KE, Niggemann B: Prevalence of adverse reactions to food in Germany - a population study. Allergy 2004;59:338-345.
16. Roehr CC, Edenharter G, Reimann S, Ehlers I, Worm M, Zuberbier T, Niggemann B: Food allergy and non-allergic food hypersensitivity in children and adolescents. Clin Exp Allergy 2004;34:1534-1541.
17. Sicherer SH, Muñz-Furlong A, Sampson HA: Prevalence of peanut and tree nut allergy. Clin Immunol 2003;112:1203-1207.
18. Kanny G, Moneret-Vautrin DA, Flabbee J, Beaudouin E, Morisset M, Thevenin F: Population study of food allergy in France. J Allergy Clin Immunol 2001;108:133-140.
19. Jacquenet S, Morisset M, Battais F, Denery-Papini S, Croizier A, Baudouin E, Bihain B, Moneret-Vautrin DA: Interest of ImmunoCAP system to recombinant omega-5 gliadin for the diagnosis of exerciseinduced wheat allergy. Int Arch Allergy Immunol 2008;149:74-80.
20. Beyer K, Chung D, Schulz G, Mishoe M, Niggemann B, Wahn U, Sampson HA: The role of wheat omega-5 gliadin IgE antibodies as a diagnostic tool for wheat allergy in childhood. J Allergy Clin Immunol 2008;122:419-421.
21. Sicherer SH, Sampson HA: Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol 2007;120:491-505.
22. Liew WK, Williamson E, Tang ML: Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 2009;123:434-442.
23. Helbling A, Hurni T, Mueller UR, Pichler WJ: Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004;34:285-290.
24. Antonicelli L, Bilò MB, Bonifazi F: Epidemiology of Hymenoptera allergy. Curr Opin Allergy Clin Immunol 2002;2:341-346.
25. Bonifazi F, Jutel M, Billò BM, Birnbaum J, Muller U; EAACI Interest Group on Insect Venom Hypersensitivity: Prevention and treatment of Hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005;60:1459-1470.
26. Golden DB: Patterns of anaphylaxis: acute and late phase features of allergic reactions; in Bock G, Goode J (eds): Anaphylaxis. Novartis Found Symp 257. Chichester, Wiley, 2004, pp 1-101.
27. Mullins RJ: Anaphylaxis: risk factors for recurrence. Clin Exp Allergy 2003;33:1033-1040.
28. Peng MM, Jick H: A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med 2004;164:317-319.
29. Thong BY, Cheng YK, Leong KP, et al: Anaphylaxis in adults referred to a clinical immunology/allergy centre in Singapore. Singapore Med J 2005;46:529-534.
30. Mehl A, Wahn U, Niggemann B: Anaphylactic reactions in children - a questionnaire-based survey in Germany. Allergy 2005;60:1440-1445.
31. Yang MS, Lee SH, Kim TW, et al: Epidemiologic and clinical features of anaphylaxis in Korea. Ann Allergy Asthma Immunol 2008;100:31-36.
32. De Swert LF, Bullens D, Raes M, Dermaux AM: Anaphylaxis in referred pediatric patients: demographic and clinical features, triggers, and therapeutic approach. Eur J Pediatr 2008;167:1251-1261.
33. Brockow K, Jofer C, Behrendt H, Ring J: Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008;63:226-232.
34. Ruëf F, Placzek M, Przybilla B: Mastocytosis and Hymenoptera venom allergy. Curr Opin Allergy Clin Immunol 2006;6:284-288.
35. Simon MR, Mulla ZD: A population-based epidemiologic analysis of deaths from anaphylaxis in Florida. Allergy 2008;63:1077-1083.
36. Sturm GJ, Heinemann A, Schuster C, et al: Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy. Allergy 2007;62: 884-889.
37. Müller UR: Bee venom allergy in beekeepers and their family members. Curr Opin Allergy Clin Immunol 2005;5:343-347.
38. Sheikh A, Alves B: Age, sex, geographical and socioeconomic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp Allergy 2001;31:1571-1576.
39. Siroux V, Curt F, Oryszczyn MP, Maccario J, Kauffmann F: Role of gender and hormone-related events on IgE, atopy, and eosinophils in the Epidemiological Study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy. J Allergy Clin Immunol 2004;114:491-498.
40. Chen W, Mempel M, Schober W, Behrendt H, Ring J: Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy 2008;63: 1418-1427.
41. Soost S, Leynaert B, Almquist C, Edenharter G, Zuberbier T, Worm M: Risk factor of adverse reactions to food in German adults. Clin Exp Allergy 2009;39:1036-1044.
42. Simons FE, Peterson S, Black CD: Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 2002;110:647-651.
43. Simons FE, Peterson S, Black CD: Epinephrine dispensing for the out-of-hospital treatment of anaphylaxis in infants and children: a population-based study. Ann Allergy Asthma Immunol 2001;86:622-626.
44. Rangaraj S, Tuthill D, Burr M, Alfaham M: Childhood epidemiology of anaphylaxis and epinephrine in Wales: 1994-1999. J Allergy Clin Immunol 2000; 109:S75.
45. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G: Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005;60: 443-451.
46. Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, Bellolio MF, Bergstralh EJ, Stead LG, Li JT: Etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008;122:1161-1165.
47. Simons FE, Sampson HA: Anaphylaxis epidemic: fact or fiction? J Allergy Clin Immunol 2008;122: 1166-1168.
48. Pumphrey RS: Fatal anaphylaxis in the UK, 1992-2001; in Bock G, Goode J (eds): Anaphylaxis. Novartis Found Symp 257. Chichester, Wiley, 2004, pp 116-128.
49. Sheikh A, Hippisley-Cox J, Newton J, Fenty J: Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 2008;101:139-143.